Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Ray-Coquard

Showing results (161-170 of 548) with videos related to

Pageof 55
Sort By:
Clinical Breast Cancer|May 13, 2009
Bevacizumab and paclitaxel for breast cancer patients with central nervous system metastases: a case seriesSana Intidhar Labidi, Thomas Bachelot, Isabelle Ray-Coquard, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 6, 2026
Joint GOG-Foundation (GOG) and European Network of Gynaecological Oncological Trial Groups (ENGOT) clinical trials guidance for operations with industry partnersRobert L Coleman, Isabelle Ray-Coquard, Thomas J Herzog, et al.
Bulletin Du Cancer|April 16, 2023
[Uterin sarcoma, high-grade stroma, indifferenciated, referential]Cyril Roussel-Simonin, Sabrina Croce, Frédéric Guyon, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 15, 2020
European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groups and industry partners - a new Model D for drug and medical device developmentNicole Concin, Isabelle Ray-Coquard, Rosalind M Glasspool, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 2, 2026
Corrigendum to "Joint GOG-Foundation (GOG) and European Network of Gynaecological Oncological Trial Groups (ENGOT) clinical trials guidance for operations with industry partners" [International Journal of Gynecological Cancer 36 (2026) 104753]Robert L Coleman, Isabelle Ray-Coquard, Thomas J Herzog, et al.
Current Gastroenterology Reports|November 14, 2008
Novel approaches to gastrointestinal stromal tumors resistant to imatinib and sunitinibPhilippe A Cassier, Armelle Dufresne, Samia Arifi, et al.
BMC Cancer|March 17, 2011
Validation of prognostic scores for survival in cancer patients beyond first-line therapyOlivier Trédan, Isabelle Ray-Coquard, Gisèle Chvetzoff, et al.
The Lancet. Haematology|December 21, 2020
Myelodysplastic syndrome and acute myeloid leukaemia in patients treated with PARP inhibitors: a safety meta-analysis of randomised controlled trials and a retrospective study of the WHO pharmacovigilance databasePierre-Marie Morice, Alexandra Leary, Charles Dolladille, et al.
Carcinogenesis|April 1, 2015
17β-estradiol inhibits spreading of metastatic cells from granulosa cell tumors through a non-genomic mechanism involving GPER1Charlotte M François, Richard Wargnier, Florence Petit, et al.
Acta Oncologica (Stockholm, Sweden)|May 29, 2024
The French multicentric molecular analysis platforms and personalized medicine trials MOST, MOST Plus and MEGAMOSTLoic Verlingue, Marine Desevre, Marie Polito, et al.
Pageof 55

Showing results (161-170 of 548) with videos related to

Sort By:
Pageof 55
Clinical Breast Cancer|May 13, 2009
Bevacizumab and paclitaxel for breast cancer patients with central nervous system metastases: a case seriesSana Intidhar Labidi, Thomas Bachelot, Isabelle Ray-Coquard, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 6, 2026
Joint GOG-Foundation (GOG) and European Network of Gynaecological Oncological Trial Groups (ENGOT) clinical trials guidance for operations with industry partnersRobert L Coleman, Isabelle Ray-Coquard, Thomas J Herzog, et al.
Bulletin Du Cancer|April 16, 2023
[Uterin sarcoma, high-grade stroma, indifferenciated, referential]Cyril Roussel-Simonin, Sabrina Croce, Frédéric Guyon, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 15, 2020
European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groups and industry partners - a new Model D for drug and medical device developmentNicole Concin, Isabelle Ray-Coquard, Rosalind M Glasspool, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 2, 2026
Corrigendum to "Joint GOG-Foundation (GOG) and European Network of Gynaecological Oncological Trial Groups (ENGOT) clinical trials guidance for operations with industry partners" [International Journal of Gynecological Cancer 36 (2026) 104753]Robert L Coleman, Isabelle Ray-Coquard, Thomas J Herzog, et al.
Current Gastroenterology Reports|November 14, 2008
Novel approaches to gastrointestinal stromal tumors resistant to imatinib and sunitinibPhilippe A Cassier, Armelle Dufresne, Samia Arifi, et al.
BMC Cancer|March 17, 2011
Validation of prognostic scores for survival in cancer patients beyond first-line therapyOlivier Trédan, Isabelle Ray-Coquard, Gisèle Chvetzoff, et al.
The Lancet. Haematology|December 21, 2020
Myelodysplastic syndrome and acute myeloid leukaemia in patients treated with PARP inhibitors: a safety meta-analysis of randomised controlled trials and a retrospective study of the WHO pharmacovigilance databasePierre-Marie Morice, Alexandra Leary, Charles Dolladille, et al.
Carcinogenesis|April 1, 2015
17β-estradiol inhibits spreading of metastatic cells from granulosa cell tumors through a non-genomic mechanism involving GPER1Charlotte M François, Richard Wargnier, Florence Petit, et al.
Acta Oncologica (Stockholm, Sweden)|May 29, 2024
The French multicentric molecular analysis platforms and personalized medicine trials MOST, MOST Plus and MEGAMOSTLoic Verlingue, Marine Desevre, Marie Polito, et al.
Pageof 55